Rongchang Pharmaceutical

Name

Rongchang Pharmaceutical

Legal name

Rongchang Pharmaceuticals, Ltd.

Website

https://en.rongchang.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

Keywords

• Traditional Chinese medicine
• Small molecule drugs
• Pharmaceutical manufacturing
• Biopharmaceutical CDMO
• Oncology drug development

Headquarters

HQ city

Yantai

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. Modern Traditional Chinese Medicine: Manufacturing and sales of modern traditional Chinese medicine products including hemorrhoid treatments, neuropsychiatric drugs, cardiovascular products, and other therapeutic categories.
2. Small Molecule and Biopharmaceuticals: Research, development, and commercialization of small molecule innovative drugs focusing on oncology and chronic diseases.
3. CDMO Services: Biopharmaceutical research and development and production services (CDMO) including biopharmaceutical company and project incubation.
4. Biopharmaceutical Incubation: Incubator services for biomedical innovation companies and projects.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Rongchang Pharmaceutical is a modern pharmaceutical manufacturer founded in 1993 and headquartered in Yantai, China, operating across four major sectors: modern traditional Chinese medicine, small molecule and biopharmaceuticals, CDMO services, and biomedical innovation incubation. The company manufactures and sells a portfolio of more than 25 pharmaceutical products spanning hemorrhoid/anorectal, neuropsychiatric, tonic, cardio-cerebrovascular, influenza, gastroenteric, gynecological, pediatric, and dermatology categories, while advancing an oncology-focused small molecule R&D pipeline targeting pan-RAS and Menin inhibitors.

Product overview

Rongchang Pharmaceutical is a modern pharmaceutical enterprise founded in 1993 and headquartered in Yantai, China, operating four major sectors: modern traditional Chinese medicine, small molecule and biopharmaceuticals, CDMO services, and biomedical innovation incubation. The company's product portfolio spans multiple therapeutic categories including hemorrhoid/anorectal treatments (Gangtai, Gangan, Zhichuang suppositories and ointments, Compound Nepeta fumigant), neuropsychiatric products (Sweet Dream oral liquid and capsule), tonics (Jiannao Bushen pills, Yupingfeng oral liquid), cardio-cerebrovascular medications (Ginkgo leaf tablets, Xinnaoshu oral liquid), influenza treatments (Compound Folium Isatidis mixture in Rx and OTC forms, New compound Folium Isatidis tablet), gastroenteric products (Soothing liver and stomach pills, Famotidine calcium magnesium chewable tablets), gynecology products (Yuetai umbilical patches, Kunning oral liquid), and pediatric medications (Xiao'er Dingchuan, Xiao'er Qingre Zhike oral liquids, Compound Folium Isatidis Suppository, Xiao'er Liuwei Zengshi Ointment). Additionally, the company offers other category products including Yinxie Granules for psoriasis and Xiaoluotong Tablets/Capsules for arthritis. The small molecule R&D division focuses on oncology with tumor targeted precision therapy and immunotherapy drugs, currently advancing RCZY-690/RCZY-680 (pan RAS inhibitors) and RCZY-711 (Menin inhibitor) in preclinical development.

Differentiator

Problem solved

Functional benefit

Products and services

• Gangtai ointment (Gangtai Ruangao) Topical hemorrhoid ointment containing Berberine Hydrochloride and Papaverine Hydrochloride for treating hemorrhoids and related symptoms. Sold to pharmacies, hospitals, and anorectal patients via distributors.
• Gangtai suppository (Gangtai Shuan) Suppository for damp-heat internal hemorrhoids, mixed hemorrhoids at stages I and II, and inflammatory external hemorrhoids with cooling, hemostatic, and analgesic properties.
• Gangan ointment (Gang An Ruangao) Topical ointment for internal, external, and mixed hemorrhoids providing cooling blood and stopping bleeding, clearing heat and removing toxicity.
• Gangan suppository (Gang An Shuan) Rectal suppository for internal, external, and mixed hemorrhoids with cooling blood and stopping bleeding, clearing heat and removing toxicity properties.
• Zhichuang suppository (Zhichuang Shuan) Traditional Chinese medicine suppository for internal hemorrhoids, mixed hemorrhoids, and mild prolapse, clearing heat to promote bowel movements, stopping bleeding, and subduing swelling to relieve pain.
• Compound Nepeta fumigant (Fufang Jingjie Xunxiji) External use granules for external hemorrhoids, mixed hemorrhoids, prolapse of internal hemorrhoid, fissured anus, perianal abscess, and acute anal fistula.
• Sweet Dream oral liquid (Tianmeng Koufuye) Neuropsychiatric tonic for dizziness, tinnitus, insomnia, amnesia, heart palpitations, and stroke sequelae, tonifying kidney qi and nourishing the heart.
• Sweet Dream oral capsule (Tianmeng Jiaonang) Neuropsychiatric capsule for cerebral hypofunction, coronary vascular diseases, cerebrovascular embolism, and alopecia with kidney qi tonifying properties.
• Jiannao Bushen pills (Jiannao Bushen Wan) Tonic for brain and kidney with ingredients including Ginseng Radix Rubra and Cervi Cornu Pantotrichum, used for forgetfulness, insomnia, and dizziness.
• Yupingfeng oral liquid (Yupingfeng Koufuye) Qi-tonifying tonic containing Astragali Radix, Saposhnikoviae Radix, and Atractylodis Macrocephalae Rhizoma for spontaneous sweating and aversion to wind.
• Ginkgo leaf tablets (Yinxingye Pian) Cardio-cerebrovascular tablet containing Ginkgo biloba extract for heart pain, wind stroke, hemiplegia, and stable angina pectoris.
• Xinnaoshu oral liquid (Xinnaoshu Koufuye) Cardio-cerebrovascular tonic for qi and yin deficiency symptoms including dizziness, insomnia, palpitations, and shortness of breath.
• Compound Folium Isatidis mixture (RX) Prescription influenza medication with dispersing wind and clearing heat, removing toxin and dispersing swelling properties for fever, headache, and viral hepatitis.
• Compound Folium Isatidis mixture (OTC) Over-the-counter influenza medication for common cold, fever, sore throat, and flu symptoms with wind-heat clearing properties.
• New compound Folium Isatidis tablet (Xinfufang Daqingye Pian) Tablet combining traditional Chinese medicine with chemical components (Acetaminophen, Caffeine, Amobarbital, Vitamin C) for cold and fever.
• Soothing liver and stomach pills (Shugan Hewei Wan) Gastroenteric pill for liver-stomach disharmony, fullness in hypochondriac regions, epigastric pain, and anorexia with liver-soothing and stomach-harmonizing properties.
• Famotidine calcium magnesium chewable tablets Compound preparation with Famotidine (10mg), Calcium Carbonate (800mg), and Magnesium Hydroxide (165mg) for relieving heartburn, acid regurgitation, and stomach discomfort.
• Yuetai umbilical patches (Yuetai Tieqi Pian) Gynecology patch applied at the umbilicus for primary dysmenorrhea caused by cold congealing and blood stasis, with Corydalis Rhizoma and Cinnamomi Cortex.
• Kunning oral liquid (Kunning Koufuye) Gynecology oral liquid for excessive menstrual bleeding and prolonged menstrual period caused by qi stagnation and blood stasis, containing Leonuri Herba and Angelicae Sinensis Radix.
• Xiao'er Dingchuan Oral Liquid Pediatric bronchodilator and expectorant for lung-heat cough and panting in children with symptoms including wheezing, thick phlegm, and fever.
• Xiao'er Qingre Zhike Oral Liquid Pediatric cold medicine for wind-heat common cold in children with symptoms including fever, coughing with yellow phlegm, and sore throat.
• Compound Folium Isatidis Suppository Pediatric rectal suppository for wind-heat cold, influenza, and mumps containing Isatidis Folium, Lonicerae Japonicae Flos, and Notopterygii Rhizoma.

Quantifiable outcome

• 2 compounds in IND-enabling stage and 2 projects in lead optimization phase
• +3 more outcomes

Segments8 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Partnerships

Five partnerships are on record, tiered minor, major and core.

• American Association for Cancer Research (AACR)minorOthers · 25 April 2025Rongchang Pharmaceutical presented its first research results at the AACR Annual Meeting 2025 in Chicago, showcasing preclinical data for RCZY-680/RCZY-690 and RCZY-711 compounds.
• Yantai Economic and Technological Development ZonemajorStrategic or Co-development Partner · 1 January 2017Partnership to establish Yantai YEDA International Incubator for Biomedical Innovation Co., Ltd. in 2017, supporting biomedical innovation and company/project incubation.
• Shandong Lutai Huanzhong Pharmaceuticals Co., Ltd.majorStrategic or Co-development Partner · 1 January 2010Acquired in 2010 and later renamed Rongchang Pharmaceuticals (Zibo) Co., Ltd., expanding manufacturing capabilities and product portfolio.
• Dr. Jianmin FangcoreStrategic or Co-development Partner · 1 January 2008Co-founded Yantai Rongchang Bioengineering Co., Ltd. (later renamed Rongchang Biopharma (Yantai) Co., Ltd.) with Dr. Jianmin Fang, a key figure in the company's biopharmaceutical expansion.
• Fudan UniversitycoreStrategic or Co-development Partner · 1 January 1996Strategic collaboration initiated in 1996 for development of recombinant human nerve growth factor (NGF), marking Rongchang's entry into the biopharmaceutical field.

Scale indicators7 records

Recent moves12 records

Expansion highlights6 records

Direct peers

• Yunnan Baiyao Group: Largest Chinese TCM/pharmaceutical conglomerate with a broad branded TCM and consumer health portfolio across multiple therapeutic categories. Directly comparable to Rongchang's modern TCM franchise and large-scale branded generics strategy in the China market.
• China Traditional Chinese Medicine Holdings (Sinopharm TCM): Major Chinese TCM-focused pharmaceutical company under Sinopharm with diversified product portfolio and significant scale. Comparable to Rongchang in TCM breadth, manufacturing footprint, and exposure to China's centralized procurement dynamics.
• Livzon Pharmaceutical Group: Mid-size Chinese pharmaceutical company combining TCM, chemical drugs, and biologics with active R&D pipeline. Closely matches Rongchang's four-pillar structure (TCM, small molecule, biologics, services) and Chinese-market focus.

Emerging players

• Hutchmed (Hutchison China MediTech): China-rooted innovative oncology and immunology company with multiple clinical-stage small molecule assets and a track record of out-licensing to global pharma. Comparable to Rongchang's small-molecule division strategic intent, although at a more advanced clinical stage.
• Pharmaron: China-headquartered CRO/CDMO offering drug discovery, preclinical, and manufacturing services with global footprint. Comparable to Rongchang's CDMO/incubation business line and biotech incubation model, though focused primarily on services rather than proprietary drug development.

Broad incumbents

• CSPC Pharmaceutical Group: Large Hong Kong-listed Chinese pharmaceutical group with both innovative drug R&D and substantial generic/TCM manufacturing. Comparable broad business mix to Rongchang, though at much larger scale and with deeper innovative pipeline.
• Tigermed (Hangzhou Tigermed Consulting): Leading Chinese clinical CRO supporting global and domestic pharma development. Relevant comparable for Rongchang's CDMO/incubation business model and biopharmaceutical services exposure, though Tigermed is more CRO-focused.
• WuXi AppTec: China's largest CRO/CDMO with global footprint, providing biopharmaceutical R&D and manufacturing services. Comparable to Rongchang's CDMO services segment, though at vastly larger scale and with broader service portfolio.
• Sino Biopharmaceutical: Large diversified Chinese pharmaceutical group spanning innovative drugs, biosimilars, and TCM/consumer health. Comparable in scale and therapeutic breadth, with both legacy cash flows and innovative pipeline exposure similar to Rongchang.
• Jiangsu Hengrui Pharmaceuticals: China's largest innovative drug company with deep oncology and chronic-disease pipeline. Comparable to Rongchang's strategic pivot toward small-molecule innovative oncology drugs, though at a much more advanced commercialization stage.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries5 records

Funding overview

Funding rounds1 record

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rongchang Pharmaceutical